Cited by 71Genetics and Neurodevelopmental DisordersGenetic Syndromes and ImprintingUbiquitin and proteasome pathways

Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology

Open access
Pandya, Nikhil J., Wang, Congwei, Costa, Veronica, Lopatta, Paul, Meier, Sonja, Zampeta, F. Isabella, Punt, A. Mattijs, Mientjes, Edwin +15 more·2021·Cell Reports Medicine

Abstract

, a ubiquitin protein ligase E3A. Here, we study neurons derived from patients with AS and neurotypical individuals, and reciprocally modulate UBE3A using antisense oligonucleotides. Unbiased proteomics reveal proteins that are regulated by UBE3A in a disease-specific manner, including PEG10, a retrotransposon-derived GAG protein. PEG10 protein increase, but not RNA, is dependent on UBE3A and proteasome function. PEG10 binds to both RNA and ataxia-associated proteins (ATXN2 and ATXN10), localizes to stress granules, and is secreted in extracellular vesicles, modulating vesicle content. Rescue of AS patient-derived neurons by UBE3A reinstatement or PEG10 reduction reveals similarity in transcriptome changes. Overexpression of PEG10 during mouse brain development alters neuronal migration, suggesting that it can affect brain development. These findings imply that PEG10 is a secreted human UBE3A target involved in AS pathophysiology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xcrm.2021.100360

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Loss of UBE3A in neurons leads to impaired ubiquitin-dependent protein degradation and widespread dysregulation of substrates important for synaptic function and neuronal excitability, consistent with a multisystem model of syndromic ASD.

    “Loss of UBE3A in neurons leads to impaired ubiquitin-dependent protein degradation and widespread dysregulation of substrates that are important for synaptic function and neuronal excitability, consistent with a multisystem model of syndromic ASD (Pandya et al., 2021).”

    From Biological hierarchy from genotype to phenotype in syndromic and non-syndromic autism spectrum disorder (2026) · cites this paper as Pandya et al., 2021

    The Results (page unavailable) show that UBE3A loss in Angelman syndrome neurons changes the abundance of several proteins and that degradation of PEG10-RF1/2 depends on UBE3A. They do not establish widespread impairment of ubiquitin-dependent degradation or dysregulation of synaptic-function and excitability substrates; the Results report no significant alteration in synaptic markers. The paper also does not present these findings as a multisystem model of syndromic ASD. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 75

  1. [1]Matsuura T. Sutcliffe J.S. Fang P. Galjaard R.J. Jiang Y.H. Benton C.S. Rommens J.M. Beaudet A.L. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome Nat. Genet. 15 1997 74 77 8988172
  2. [2]Fang P. Lev-Lehman E. Tsai T.F. Matsuura T. Benton C.S. Sutcliffe J.S. Christian S.L. Kubota T. Halley D.J. Meijers-Heijboer H. The spectrum of mutations in UBE3A causing Angelman syndrome Hum. Mol. Genet. 8 1999 129 135 9887341
  3. [3]Cook E.H. Jr. Lindgren V. Leventhal B.L. Courchesne R. Lincoln A. Shulman C. Lord C. Courchesne E. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication Am. J. Hum. Genet. 60 1997 928 934 9106540 PMC1712464
  4. [4]Clayton-Smith J. Laan L. Angelman syndrome: a review of the clinical and genetic aspects J. Med. Genet. 40 2003 87 95 12566516 PMC1735357
  5. [5]Buiting K. Williams C. Horsthemke B. Angelman syndrome - insights into a rare neurogenetic disorder Nat. Rev. Neurol. 12 2016 584 593 27615419
  6. [6]Chamberlain S.J. Lalande M. Angelman syndrome, a genomic imprinting disorder of the brain J. Neurosci. 30 2010 9958 9963 20668179 PMC6633366
  7. [8]Meng L. Ward A.J. Chun S. Bennett C.F. Beaudet A.L. Rigo F. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA Nature 518 2015 409 412 25470045 PMC4351819
  8. [9]Sonzogni M. Wallaard I. Santos S.S. Kingma J. du Mee D. van Woerden G.M. Elgersma Y. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants Mol. Autism 9 2018 47 30220990 PMC6137919
  9. [10]Rotaru D.C. Mientjes E.J. Elgersma Y. Angelman Syndrome: From Mouse Models to Therapy Neuroscience 445 2020 172 189 32088294
  10. [11]Chamberlain S.J. Chen P.F. Ng K.Y. Bourgois-Rocha F. Lemtiri-Chlieh F. Levine E.S. Lalande M. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes Proc. Natl. Acad. Sci. USA 107 2010 17668 17673 20876107 PMC2955112
  11. [12]Fink J.J. Robinson T.M. Germain N.D. Sirois C.L. Bolduc K.A. Ward A.J. Rigo F. Chamberlain S.J. Levine E.S. Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells Nat. Commun. 8 2017 15038 28436452 PMC5413969
  12. [13]Frohlich J. Miller M.T. Bird L.M. Garces P. Purtell H. Hoener M.C. Philpot B.D. Sidorov M.S. Tan W.H. Hernandez M.C. Electrophysiological phenotype in Angelman syndrome differs between genotypes Biol. Psychiatry 85 2019 752 759 30826071 PMC6482952
  13. [14]Huang H.S. Burns A.J. Nonneman R.J. Baker L.K. Riddick N.V. Nikolova V.D. Riday T.T. Yashiro K. Philpot B.D. Moy S.S. Behavioral deficits in an Angelman syndrome model: effects of genetic background and age Behav. Brain Res. 243 2013 79 90 23295389 PMC3629944
  14. [15]Pandya N.J. Avila D. Dunkley T. Jagasia R. Tzouros M. TMT-MS3-Enabled proteomic quantification of human IPSC-Derived neurons Li K.W. Neuroproteomics 2019 Springer 103 117
  15. [16]Oughtred R. Stark C. Breitkreutz B.J. Rust J. Boucher L. Chang C. Kolas N. O’Donnell L. Leung G. McAdam R. The BioGRID interaction database: 2019 update Nucleic Acids Res. 47 D1 2019 D529 D541 30476227 PMC6324058
  16. [17]Dunkley T. Costa V. Friedlein A. Lugert S. Aigner S. Ebeling M. Miller M.T. Patsch C. Piraino P. Cutler P. Jagasia R. Characterization of a human pluripotent stem cell-derived model of neuronal development using multiplexed targeted proteomics Proteomics Clin. Appl. 9 2015 684 694 25684324
  17. [18]Costa V. Aigner S. Vukcevic M. Sauter E. Behr K. Ebeling M. Dunkley T. Friedlein A. Zoffmann S. Meyer C.A. MTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis Cell Rep. 15 2016 86 95 27052171
  18. [19]Kruse R. Krantz J. Barker N. Coletta R.L. Rafikov R. Luo M. Højlund K. Mandarino L.J. Langlais P.R. Characterization of the CLASP2 protein interaction network identifies SOGA1 as a microtubule-associated protein Mol. Cell. Proteomics 16 2017 1718 1735 28550165 PMC5629260
  19. [20]Burette A.C. Judson M.C. Burette S. Phend K.D. Philpot B.D. Weinberg R.J. Subcellular organization of UBE3A in neurons J. Comp. Neurol. 525 2017 233 251 27339004 PMC5138109
  20. [22]Santini E. Turner K.L. Ramaraj A.B. Murphy M.P. Klann E. Kaphzan H. Mitochondrial superoxide contributes to hippocampal synaptic dysfunction and memory deficits in Angelman syndrome model mice J. Neurosci. 35 2015 16213 16220 26658871 PMC4682786
  21. [23]Llewellyn K.J. Nalbandian A. Gomez A. Wei D. Walker N. Kimonis V.E. Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome Neurobiol. Dis. 76 2015 77 86 25684537
  22. [24]Avagliano Trezza R. Sonzogni M. Bossuyt S.N.V. Zampeta F.I. Punt A.M. van den Berg M. Rotaru D.C. Koene L.M.C. Munshi S.T. Stedehouder J. Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome Nat. Neurosci. 22 2019 1235 1247 31235931
  23. [25]Zampeta F.I. Sonzogni M. Niggl E. Lendemeijer B. Smeenk H. de Vrij F.M.S. Kushner S.A. Distel B. Elgersma Y. Conserved UBE3A subcellular distribution between human and mice is facilitated by non-homologous isoforms Hum. Mol. Genet. 29 2020 3032 3043 32879944 PMC7645710
  24. [26]Jacobson A.D. MacFadden A. Wu Z. Peng J. Liu C.W. Autoregulation of the 26S proteasome by in situ ubiquitination Mol. Biol. Cell 25 2014 1824 1835 24743594 PMC4055262
  25. [27]Utine G.E. Taşkıran E.Z. Koşukcu C. Karaosmanoğlu B. Güleray N. Doğan Ö.A. Kiper P.Ö. Boduroğlu K. Alikaşifoğlu M. HERC1 mutations in idiopathic intellectual disability Eur. J. Med. Genet. 60 2017 279 283 28323226
  26. [28]Morice-Picard F. Benard G. Rezvani H.R. Lasseaux E. Simon D. Moutton S. Rooryck C. Lacombe D. Baumann C. Arveiler B. Complete loss of function of the ubiquitin ligase HERC2 causes a severe neurodevelopmental phenotype Eur. J. Hum. Genet. 25 2016 52 58 27759030 PMC5159772
  27. [29]Harlalka G.V. Baple E.L. Cross H. Kühnle S. Cubillos-Rojas M. Matentzoglu K. Patton M.A. Wagner K. Coblentz R. Ford D.L. Mutation of HERC2 causes developmental delay with Angelman-like features J. Med. Genet. 50 2013 65 73 23243086
  28. [30]Martínez-Noël G. Galligan J.T. Sowa M.E. Arndt V. Overton T.M. Harper J.W. Howley P.M. Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes Mol. Cell. Biol. 32 2012 3095 3106 22645313 PMC3434508
  29. [31]Kühnle S. Kogel U. Glockzin S. Marquardt A. Ciechanover A. Matentzoglu K. Scheffner M. Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2 J. Biol. Chem. 286 2011 19410 19416 21493713 PMC3103319
  30. [32]Horie M. Watanabe K. Bepari A.K. Nashimoto J. Araki K. Sano H. Chiken S. Nambu A. Ono K. Ikenaka K. Disruption of actin-binding domain-containing Dystonin protein causes dystonia musculorum in mice Eur. J. Neurosci. 40 2014 3458 3471 25195653
  31. [33]Wang Y. Kaneko N. Asai N. Enomoto A. Isotani-Sakakibara M. Kato T. Asai M. Murakumo Y. Ota H. Hikita T. Girdin is an intrinsic regulator of neuroblast chain migration in the rostral migratory stream of the postnatal brain J. Neurosci. 31 2011 8109 8122 21632933 PMC5491307
  32. [34]Baker J.D. Shelton L.B. Zheng D. Favretto F. Nordhues B.A. Darling A. Sullivan L.E. Sun Z. Solanki P.K. Martin M.D. Human cyclophilin 40 unravels neurotoxic amyloids PLoS Biol. 15 2017 e2001336 28654636 PMC5486962
  33. [35]Lorenzi M.V. Castagnino P. Chen Q. Hori Y. Miki T. Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42 Oncogene 18 1999 4742 4755 10467422
  34. [36]Abed M. Verschueren E. Budayeva H. Liu P. Kirkpatrick D.S. Reja R. Kummerfeld S.K. Webster J.D. Gierke S. Reichelt M. The Gag protein PEG10 binds to RNA and regulates trophoblast stem cell lineage specification PLoS ONE 14 2019 e0214110 30951545 PMC6450627
  35. [37]Campillos M. Doerks T. Shah P.K. Bork P. Computational characterization of multiple Gag-like human proteins Trends Genet. 22 2006 585 589 16979784
  36. [38]Clark M.B. Jänicke M. Gottesbühren U. Kleffmann T. Legge M. Poole E.S. Tate W.P. Mammalian gene PEG10 expresses two reading frames by high efficiency -1 frameshifting in embryonic-associated tissues J. Biol. Chem. 282 2007 37359 37369 17942406
  37. [40]Huttlin E.L. Bruckner R.J. Paulo J.A. Cannon J.R. Ting L. Baltier K. Colby G. Gebreab F. Gygi M.P. Parzen H. Architecture of the human interactome defines protein communities and disease networks Nature 545 2017 505 509 28514442 PMC5531611
  38. [41]Avagliano Trezza R. Punt A.M. Mientjes E. van den Berg M. Zampeta F.I. de Graaf I.J. van der Weegen Y. Demmers J.A.A. Elgersma Y. Distel B. Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function Sci. Rep. 11 2021 3007 33542309 PMC7862399
  39. [42]Zaaroor-Regev D. de Bie P. Scheffner M. Noy T. Shemer R. Heled M. Stein I. Pikarsky E. Ciechanover A. Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome Proc. Natl. Acad. Sci. USA 107 2010 6788 6793 20351251 PMC2872415
  40. [43]Skogberg G. Gudmundsdottir J. van der Post S. Sandström K. Bruhn S. Benson M. Mincheva-Nilsson L. Baranov V. Telemo E. Ekwall O. Characterization of human thymic exosomes PLoS ONE 8 2013 e67554 23844026 PMC3699640
  41. [44]Hurwitz S.N. Rider M.A. Bundy J.L. Liu X. Singh R.K. Meckes D.G. Jr. Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers Oncotarget 7 2016 86999 87015 27894104 PMC5341331
  42. [45]Nonhoff U. Ralser M. Welzel F. Piccini I. Balzereit D. Yaspo M.L. Lehrach H. Krobitsch S. Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules Mol. Biol. Cell 18 2007 1385 1396 17392519 PMC1838996
  43. [46]Paul S. Dansithong W. Figueroa K.P. Scoles D.R. Pulst S.M. Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration Nat. Commun. 9 2018 3648 30194296 PMC6128856
  44. [47]Youn J.Y. Dunham W.H. Hong S.J. Knight J.D.R. Bashkurov M. Chen G.I. Bagci H. Rathod B. MacLeod G. Eng S.W.M. High-density proximity mapping reveals the subcellular organization of mRNA-associated granules and bodies Mol. Cell 69 2018 517 532.e11 29395067
  45. [48]Cinti A. Le Sage V. Ghanem M. Mouland A.J. HIV-1 gag blocks selenite-induced stress granule assembly by altering the mRNA cap-binding complex MBio 7 2016 e00329 27025252 PMC4817256
  46. [49]Reineke L.C. Lloyd R.E. Diversion of stress granules and P-bodies during viral infection Virology 436 2013 255 267 23290869 PMC3611887
  47. [50]Wheeler J.R. Matheny T. Jain S. Abrisch R. Parker R. Distinct stages in stress granule assembly and disassembly eLife 5 2016 e18413 27602576 PMC5014549
  48. [51]Liu Y.B. Tewari A. Salameh J. Arystarkhova E. Hampton T.G. Brashear A. Ozelius L.J. Khodakhah K. Sweadner K.J. A dystonia-like movement disorder with brain and spinal neuronal defects is caused by mutation of the mouse laminin β1 subunit, Lamb1 eLife 4 2015 e11102 26705335 PMC4749547
  49. [52]Ahmed M. Marziali L.N. Arenas E. Feltri M.L. Ffrench-Constant C. Laminin α2 controls mouse and human stem cell behaviour during midbrain dopaminergic neuron development Development 146 2019 dev172668 31371375 PMC6737905
  50. [53]Chen L. Chu C. Kong X. Huang T. Cai Y.D. Discovery of new candidate genes related to brain development using protein interaction information PLoS ONE 10 2015 e0118003 25635857 PMC4311913
  51. [55]Jäkel S. Agirre E. Mendanha Falcão A. van Bruggen D. Lee K.W. Knuesel I. Malhotra D. Ffrench-Constant C. Williams A. Castelo-Branco G. Altered human oligodendrocyte heterogeneity in multiple sclerosis Nature 566 2019 543 547 30747918 PMC6544546
  52. [56]Zhang Y. Sloan S.A. Clarke L.E. Caneda C. Plaza C.A. Blumenthal P.D. Vogel H. Steinberg G.K. Edwards M.S.B. Li G. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse Neuron 89 2016 37 53 26687838 PMC4707064
  53. [60]Yi J.J. Paranjape S.R. Walker M.P. Choudhury R. Wolter J.M. Fragola G. Emanuele M.J. Major M.B. Zylka M.J. The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome J. Biol. Chem. 292 2017 12503 12515 28559284 PMC5535025
  54. [62]Ono R. Nakamura K. Inoue K. Naruse M. Usami T. Wakisaka-Saito N. Hino T. Suzuki-Migishima R. Ogonuki N. Miki H. Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality Nat. Genet. 38 2006 101 106 16341224
  55. [63]Golda M. Mótyán J.A. Mahdi M. Tőzsér J. Functional study of the retrotransposon-derived human PEG10 protease Int. J. Mol. Sci. 21 2020 E2424 32244497 PMC7212762
  56. [64]Whiteley A.M. Prado M.A. de Poot S.A.H. Paulo J.A. Ashton M. Dominguez S. Weber M. Ngu H. Szpyt J. Jedrychowski M.P. Global proteomics of Ubqln2-based murine models of ALS J. Biol. Chem. 296 2021 100153 33277362 PMC7873701
  57. [65]Blokhuis A.M. Koppers M. Groen E.J.N. van den Heuvel D.M.A. Dini Modigliani S. Anink J.J. Fumoto K. van Diggelen F. Snelting A. Sodaar P. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways Acta Neuropathol. 132 2016 175 196 27164932 PMC4947123
  58. [66]Pastuzyn E.D. Day C.E. Kearns R.B. Kyrke-Smith M. Taibi A.V. McCormick J. Yoder N. Belnap D.M. Erlendsson S. Morado D.R. The neuronal gene arc encodes a repurposed retrotransposon gag protein that mediates intercellular RNA transfer Cell 172 2018 275 288.e18 29328916 PMC5884693
  59. [67]Ashley J. Cordy B. Lucia D. Fradkin L.G. Budnik V. Thomson T. Retrovirus-like gag protein Arc1 binds RNA and traffics across synaptic boutons Cell 172 2018 262 274.e11 29328915 PMC5793882
  60. [68]Kühnle S. Mothes B. Matentzoglu K. Scheffner M. Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc Proc. Natl. Acad. Sci. USA 110 2013 8888 8893 23671107 PMC3670309
  61. [69]Koopmans F. Pandya N.J. Franke S.K. Phillippens I.H.C.M.H. Paliukhovich I. Li K.W. Smit A.B. Comparative hippocampal synaptic proteomes of rodents and primates: differences in neuroplasticity-related proteins Front. Mol. Neurosci. 11 2018 364 30333727 PMC6176546
  62. [71]Pandya N.J. Seeger C. Babai N. Gonzalez-Lozano M.A. Mack V. Lodder J.C. Gouwenberg Y. Mansvelder H.D. Danielson U.H. Li K.W. Noelin1 affects lateral mobility of synaptic AMPA receptors Cell Rep. 24 2018 1218 1230 30067977 PMC6088136
  63. [72]Plubell D.L. Wilmarth P.A. Zhao Y. Fenton A.M. Minnier J. Reddy A.P. Klimek J. Yang X. David L.L. Pamir N. Extended multiplexing of tandem mass tags (TMT) labeling reveals age and high fat diet specific proteome changes in mouse epididymal adipose tissue Mol. Cell. Proteomics 16 2017 873 890 28325852 PMC5417827
  64. [73]Ritchie M.E. Phipson B. Wu D. Hu Y. Law C.W. Shi W. Smyth G.K. limma powers differential expression analyses for RNA-sequencing and microarray studies Nucleic Acids Res. 43 2015 e47 25605792 PMC4402510
  65. [74]Phipson B. Lee S. Majewski I.J. Alexander W.S. Smyth G.K. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression Ann. Appl. Stat. 10 2016 946 963 28367255 PMC5373812
  66. [75]Hothorn T. Bretz F. Westfall P. Simultaneous inference in general parametric models Biom. J. 50 2008 346 363 18481363
  67. [79]Gkourtsa A. van den Burg J. Avula T. Hochstenbach F. Distel B. Binding of a proline-independent hydrophobic motif by the Candida albicans Rvs167-3 SH3 domain Microbiol. Res. 190 2016 27 36 27393996
  68. [80]Nelson J.K. Sorrentino V. Avagliano Trezza R. Heride C. Urbe S. Distel B. Zelcer N. The deubiquitylase USP2 regulates the ldlr pathway by counteracting the E3-ubiquitin Ligase IDOL Circ. Res. 118 2016 410 419 26666640
  69. [81]Witwer K.W. Buzás E.I. Bemis L.T. Bora A. Lässer C. Lötvall J. Nolte-’t Hoen E.N. Piper M.G. Sivaraman S. Skog J. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research J. Extracell. Vesicles 2 2013 10.3402/jev.v2i0.20360 PMC3760646 24009894 · DOI
  70. [82]Saito T. In vivo electroporation in the embryonic mouse central nervous system Nat. Protoc. 1 2006 1552 1558 17406448
  71. [83]Taniguchi Y. Young-Pearse T. Sawa A. Kamiya A. In utero electroporation as a tool for genetic manipulation in vivo to study psychiatric disorders: from genes to circuits and behaviors Neuroscientist 18 2012 169 179 21551077 PMC3530425
  72. [84]Dobin A. Davis C.A. Schlesinger F. Drenkow J. Zaleski C. Jha S. Batut P. Chaisson M. Gingeras T.R. STAR: ultrafast universal RNA-seq aligner Bioinformatics 29 2013 15 21 23104886 PMC3530905
  73. [85]Li H. Handsaker B. Wysoker A. Fennell T. Ruan J. Homer N. Marth G. Abecasis G. Durbin R. 1000 Genome Project Data Processing Subgroup The Sequence Alignment/Map format and SAMtools Bioinformatics 25 2009 2078 2079 19505943 PMC2723002
  74. [86]Robinson M.D. McCarthy D.J. Smyth G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data Bioinformatics 26 2010 139 140 19910308 PMC2796818
  75. [87]McCarthy D.J. Chen Y. Smyth G.K. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation Nucleic Acids Res. 40 2012 4288 4297 22287627 PMC3378882

Cited by

Sorted by citations

Authors
Pandya, N. J., Wang, C., Costa, V., Lopatta, P., Meier, S., Zampeta, F. I., Punt, A. M., Mientjes, E., Grossen, P., Distler, T., Tzouros, M., Martí, Y., Banfai, B., Patsch, C., Rasmussen, S., Hoener, M., Berrera, M., Kremer, T., Dunkley, T., Ebeling, M., Distel, B., Elgersma, Y., & Jagasia, R.
Affiliations
  • F. Hoffmann-La Roche AG (CH)
  • Erasmus MC (NL)
Corresponding author
  • Pandya, Nikhil J.
  • Jagasia, Ravi
Venue
Cell Reports Medicine
Publisher
Elsevier BV
Published
2021-08
Volume
2
Issue
8
Pages
100360
ISSN
2666-3791 (ISSN-L)
OpenAlex
W3194032651
Cited by
71
References
9
Citations by year
2026: 16 · 2025: 12 · 2024: 23 · 2023: 12 · 2022: 7 · 2021: 1
FWCI
6.08
Type
journal article
Language
en
Open access
Locations
  • Cell Reports Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • Pure Amsterdam UMC (acceptedVersion, cc-by-nc-nd)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
Funders
  • Boston Children's Hospital
  • Roche (WO2020/148310)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
PEG10, UBE3A, Angelman syndrome, secreted proteins, extracellular vesicles, stress granules, ATXN2, proteasome, antisense oligonucleotides, neuronal migration, brain development, transcriptome changes, patient-derived neurons
MeSH terms
Extracellular Vesicles, Protein Domains, Stress Granules, Animals, Cell Movement, Child, Preschool, DNA-Binding Proteins, Female, Humans, Male, Mice, Inbred C57BL, Neurons, Retroviridae, Gene Products, gag, RNA-Binding Proteins, Angelman Syndrome, Retroelements, Ubiquitin-Protein Ligases, Proteasome Endopeptidase Complex, Apoptosis Regulatory Proteins, Mice, Induced Pluripotent Stem Cells, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review